Etanercept 50mg Injection$138.00
1–9 boxes
$138.00 each
10–24 boxes
8% off
25+ boxes
10% off
Etanercept 50mg Injection
SKU GME721Product Introduction
Etanercept 50mg Injection is a TNF-blocking biologic used for selected inflammatory joint diseases and plaque psoriasis. It is not interchangeable with every other TNF inhibitor's indications, particularly inflammatory bowel disease.
How to use
Administer the prefilled syringe subcutaneously after injection training, using the indication-specific schedule. Rotate sites and avoid bruised, inflamed or damaged skin. Do not shake the syringe or inject any product that has frozen.
How it works
The soluble receptor fusion protein binds tumour necrosis factor and limits its interaction with cell-surface receptors involved in inflammation.
Side effects
Injection-site redness or discomfort, headache and respiratory infections may occur.
Important information
Screen for tuberculosis and hepatitis B risk before treatment. Serious infections, demyelinating disease, heart failure and malignancy concerns require assessment; avoid live vaccines during treatment.
Uses
- Selected rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, juvenile idiopathic arthritis and plaque psoriasis
Benefits
Can reduce inflammatory disease activity and improve function in the indicated joint or skin disorder.
Why screen for tuberculosis before treatment?
TNF blockade can reactivate latent tuberculosis.
Is it routinely used for Crohn's disease?
No. Do not assume the inflammatory-bowel-disease indications of other TNF inhibitors apply to etanercept.
Should treatment continue during a serious infection?
Contact the treating team promptly; serious infection usually requires interruption and assessment.
Can the injection be shaken?
No. Shaking can damage the protein preparation.
Can live vaccines be given during treatment?
They should generally be avoided; arrange vaccination planning in advance.
Why mention previous hepatitis B?
Reactivation is possible and may require specialist monitoring or prevention.
Can heart failure affect suitability?
Yes. New or worsening heart failure has been reported.
Can a different biologic be added without review?
No. Combining biologic immunosuppressants can substantially increase serious-infection risk.
TNF: tumour necrosis factor, an inflammatory signalling protein. Biologic: a medicine produced using biological systems. Latent tuberculosis: TB infection without active disease symptoms.; AR: Etanercept 50mg حقن; FR: Etanercept 50mg injection; PT: Etanercept 50mg injeção; ES: Etanercept 50mg inyección; RU: Etanercept 50mg инъекция; ID: Etanercept 50mg injeksi; VI: Etanercept 50mg thuốc tiêm; MS: Etanercept 50mg suntikan; TL: Etanercept 50mg iniksyon; ZH-SG: Etanercept 50mg 注射剂